| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 01/12/2012 | US20120009210 Hypallergenic mosaic antigens and methods of making same |
| 01/12/2012 | US20120009206 Novel double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activity |
| 01/12/2012 | US20120009202 Target host factors for treating viral infection |
| 01/12/2012 | US20120009201 Renal cell carcinoma biomarkers |
| 01/12/2012 | US20120009194 Antibodies to endoplasmin and their use |
| 01/12/2012 | US20120009190 Identification and method for using the pre-ligand assembly domain of the il-17 receptor |
| 01/12/2012 | US20120009188 Optimized fc variants |
| 01/12/2012 | US20120009187 Cloning and recombinant productions of vespula venom protease and methods of use thereof |
| 01/12/2012 | US20120009162 T cell receptor and nucleic acid encoding the receptor |
| 01/12/2012 | US20120009161 Therapeutic retroviral vectors for gene therapy |
| 01/12/2012 | US20120009130 Viral Therapy and Prophylaxis Using Nanotechnology Delivery Techniques |
| 01/12/2012 | DE102008063592B4 Multifunktionaler Laborprozessbeutel für die Reinherstellung von Biomolekülen Multifunctional Laboratory Process bag for clean production of biomolecules |
| 01/12/2012 | CA2804214A1 Methods and compositions for the specific inhibition of beta-catenin by double-stranded rna |
| 01/12/2012 | CA2804210A1 Methods and compositions for the specific inhibition of androgen receptor by double-stranded rna |
| 01/11/2012 | EP2405024A1 Hot start reverse transcription by primer design |
| 01/11/2012 | EP2405015A2 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 01/11/2012 | EP2404931A1 Glucanases, nucleic acids encoding them and methods for making and using them |
| 01/11/2012 | EP2404929A1 Glucanases, nucleic acids encoding them and methods for making and using them |
| 01/11/2012 | EP2404928A1 Glucanases, nucleic acids encoding them and methods for making and using them |
| 01/11/2012 | EP2404927A2 Isolation of five novel genes coding for new fc receptors-type melanoma involved in the pathogenesis of lymphoma/melanoma |
| 01/11/2012 | EP2404676A1 Microfluidic Control Structures |
| 01/11/2012 | EP2404499A2 Nucleic acid molecules encoding Lipid Metabolism Protein (LMP) and methods of use in plants |
| 01/11/2012 | EP1986696B1 Method for production of a transformed cell |
| 01/11/2012 | EP1802774B1 Reagents and methods for improving reproducibility and reducing mispriming in pcr amplification |
| 01/11/2012 | EP1511845B1 Immunostimulatory oligonucleotides and uses thereof |
| 01/11/2012 | EP1483384B1 Method for overexpression of zwitterionic polysaccharides |
| 01/11/2012 | EP1395108B1 Sugar and lipid metabolism regulators in plants |
| 01/11/2012 | EP1019432B1 The ob receptor and methods of diagnosing and treating weight |
| 01/11/2012 | CN1948483B SiRNA for inhibiting human Rabj gene expression and its application |
| 01/11/2012 | CN1948482B Antisensedigonucleotides sequence for inhibiting human Rabj gene expression and its application |
| 01/11/2012 | CN102317475A Template-independent ligation of single-stranded DNA |
| 01/11/2012 | CN102317303A Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders |
| 01/11/2012 | CN101712725B New dialyzing technology in preparation process of bacilli calmette-guerin (BCG) polyose nuclear acid |
| 01/10/2012 | USRE43097 Massively parallel signature sequencing by ligation of encoded adaptors |
| 01/10/2012 | US8095323 Polymorphism detection |
| 01/10/2012 | US8093457 Storage-induced promoter |
| 01/10/2012 | US8093450 Non-aggregating fluorescent proteins and methods for using the same |
| 01/10/2012 | US8093397 Activators for oligonucleotide synthesis |
| 01/10/2012 | US8093373 Plasmid purification |
| 01/10/2012 | US8093372 Contacting with nucleophilic compound |
| 01/10/2012 | US8093371 Method of producing a nucleic acid |
| 01/10/2012 | US8093370 siRNA targeting spleen tyrosine kinase |
| 01/10/2012 | US8093369 Compositions for silencing the expression of VDAC1 and uses thereof |
| 01/10/2012 | US8093368 DR5 gene promoter and SIAH-1 gene promoter |
| 01/10/2012 | US8093367 Preparation and isolation of 5′ capped mRNA |
| 01/10/2012 | US8093366 Dbait and standalone uses thereof |
| 01/10/2012 | US8093286 Methods for treatment with bucindolol based on genetic targeting |
| 01/10/2012 | US8093225 Gene expression and pain |
| 01/10/2012 | US8093224 Antisense modulation of C-reactive protein expression |
| 01/10/2012 | US8093222 Methods for treating hypercholesterolemia |
| 01/10/2012 | US8093186 Biopolymeric arrays having replicate elements |
| 01/10/2012 | US8093063 Assay for detecting genetic abnormalities in genomic nucleic acids |
| 01/10/2012 | US8093043 β-TrCP1, β-TrCP2 and RSK1 or RSK2 inhibitors and methods for sensitizing target cells to apoptosis |
| 01/10/2012 | US8093036 Methods for producing hyaluronan in a recombinant host cell |
| 01/10/2012 | US8093032 Mutants of streptokinase and their covalently modified forms |
| 01/10/2012 | US8093029 Bilirubin oxidase mutant having thermal stability |
| 01/10/2012 | US8093021 Defective sindbis viral vectors |
| 01/10/2012 | US8093016 Use of an aspartic protease (NS24) signal sequence for heterologous protein expression |
| 01/10/2012 | US8093004 Method of detecting and predicting bronchodilatory response to beta agonist |
| 01/10/2012 | US8093003 Fluorescence energy transfer by competitive hybridization |
| 01/10/2012 | US8093002 Amplicon melting analysis with saturation dyes |
| 01/10/2012 | US8093001 Detection and diagnosis of smoking related cancers |
| 01/10/2012 | US8092996 Method for detecting cystic fibrosis |
| 01/10/2012 | US8092992 Transcriptional regulation of gene expression by small double-stranded modulatory RNA |
| 01/10/2012 | US8092991 De novo enzymatic production of nucleic acid molecules |
| 01/10/2012 | US8092899 Method of activating a silicon surface for subsequent patterning of molecules onto said surface |
| 01/10/2012 | US8092819 Implantable medical device coated with a bioactive agent |
| 01/10/2012 | US8092797 using monoclonal antibody or an Fab fragment capable of binding to mouse Vascular endothelial cell growth factor (VEGF) and human VEGF; cancer, diabetes related diseases, age-induced macular degeneration |
| 01/10/2012 | US8092794 Pharmaceutical compositions comprising SODs and prolamine based peptide fragments |
| 01/10/2012 | US8092531 Human skin equivalents expressing exogenous polypeptides |
| 01/10/2012 | CA2505758C Cftr allele detection assays |
| 01/10/2012 | CA2444918C Labelling reagents, method for synthesis of said reagents and methods for detecting biological molecules |
| 01/10/2012 | CA2436665C Nucleic acid derivatives |
| 01/10/2012 | CA2416963C Methods and compositions for amplification of rna sequences |
| 01/10/2012 | CA2404488C Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis |
| 01/10/2012 | CA2262411C Resistance against nematodes and/or aphids |
| 01/10/2012 | CA2247922C Genetic sequences encoding flavonoid pathway enzymes and uses therefor |
| 01/05/2012 | WO2012003388A1 Primer beads |
| 01/05/2012 | WO2012001126A1 A new method of using n-thio compounds for oligonucleotide synthesis |
| 01/05/2012 | WO2012000153A1 High resolution typing method of hla gene based on illumina ga sequencing technology |
| 01/05/2012 | WO2011143511A3 Methods for producing enteroendocrine cells that make and secrete insulin |
| 01/05/2012 | WO2011139994A3 Genetic elements, proteins, and associated methods including application of additional genetic information to gram (+) thermoacidophiles |
| 01/05/2012 | WO2011133901A3 Aav-based treatment of cholesterol-related disorders |
| 01/05/2012 | WO2011125055A3 Synthetic constructs for polynucleotide and protein expression |
| 01/05/2012 | WO2011103468A3 Phosphoramidites for synthetic rna in the reverse direction |
| 01/05/2012 | WO2011094358A9 Influenza nucleic acid molecules and vaccines made therefrom |
| 01/05/2012 | WO2010033225A3 Compositions and methods for the specific inhibition of gene expression by dsrna |
| 01/05/2012 | WO2002092832A9 Human and non-human primate homologues of nkd protein, nucleic acid sequences encoding, and uses thereof |
| 01/05/2012 | US20120005785 Plants having improved growth characteristics and method for making the same |
| 01/05/2012 | US20120005780 UDP-Xylose Synthases (UXS) Polynucleotides, Polypeptides and Uses Thereof |
| 01/05/2012 | US20120005779 Plastidic phosphoglucomutase genes |
| 01/05/2012 | US20120005778 Brittle stalk 2 gene family and related methods and uses |
| 01/05/2012 | US20120005777 Process for the Production of Fine Chemicals |
| 01/05/2012 | US20120005775 Nitrate transport components |
| 01/05/2012 | US20120005767 Antibodies to insulin-like growth factor i receptor |
| 01/05/2012 | US20120004592 Compositions for solubilizing tissue |
| 01/05/2012 | US20120004403 RNA INTERFERENCE MEDIATED INHIBITION OF TNF AND TNF RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 01/05/2012 | US20120004402 Crh and pomc effects on animal growth |
| 01/05/2012 | US20120004391 Cyanine-type compounds having an alkynyl linker arm |
| 01/05/2012 | US20120004290 Treating chronic fatigue syndrome and prolonged qt interval |